まとめ
鳥類白血病ウイルス (ALV) のプロウイルスは,リンパ腫におけるc-myc腫瘍遺伝子を活性化します. これは,様々な近接性と指向の構成を通じて発生し,単純なプロモーター効果を超えた新しい遺伝子活性化メカニズムを示唆します.
科学分野:
- 腫瘍学 腫瘍学
- ウイルス学 ウイルス学 ウイルス学
- 分子生物学は分子生物学である.
背景:
- 鳥類白血病ウイルス (ALV) は,ブルスリンパ腫と関連しています.
- c-mycのような細胞腫瘍遺伝子は,がんの発症に作用する.
- 腫瘍遺伝子の活性化を理解することは,がん研究にとって極めて重要です.
研究 の 目的:
- リンパ腫におけるALVプロウイルスとc-myc発現の関係を調査する.
- 強化されたc-myc発現に関連したプロウイルス統合の特定の構成を特定する.
- 細胞遺伝子を活性化するレトロウイルスDNAのメカニズムを探求する.
主な方法:
- ALV誘発のブルサリンパ腫の分析.
- c-myc腫瘍遺伝子の相対的なALVプロウイルスの位置をマッピングする.
- c-myc遺伝子発現レベルを評価する.
主要な成果:
- ALVプロウイルスは,リンパ腫のc-myc腫瘍遺伝子の近くで見つかりました.
- 強化されたc-myc発現は,3つの異なる構成のプロウイルスと相関しています: 5'同じ方向性,3'同じ方向性,5'反対方向性.
- これらの発見は,転写プロモーターから独立した遺伝子活性化のメカニズムを示しています.
結論:
- 細胞腫瘍遺伝子の近くのレトロウイルスの統合は,それらの発現の強化につながる可能性があります.
- c-mycに対するプロウイルスの空間的および指向的配置は,遺伝子活性化に影響を与える.
- レトロウイルスDNAによる細胞遺伝子の活性化には,単純なプロモーター挿入以上のメカニズムが含まれています.
関連する概念動画
00:57Viral Recombination
Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
01:51Mechanisms of Retrovirus-induced Cancers
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
01:03Rous Sarcoma Virus (RSV) and Cancer
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
01:51Mechanisms of Retrovirus-induced Cancers
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
01:03Rous Sarcoma Virus (RSV) and Cancer
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
01:24B Cell Activation and Differentiation
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...